MCI Diagnostic Opens Dallas Headquarters

DALLAS, Nov. 27, 2020 /PRNewswire/ -- MCI Diagnostic Center, a Service-Disabled Veteran Owned small business that offers national laboratory testing and diagnostics in all 50 states, officially introduced the Dallas community to its new state-of-the-art laboratory and staff. MCI expanded from its headquarters in Tulsa, Oklahoma to a second one in Dallas, Texas located at 9728 Greenville Avenue.  

MCI Diagnostic Center is an SBA HUBZone certified and accredited by CLIA, CAP, COLA and FDA. "We are providing a wonderful service in this time of need for our country. I thank each of you for coming and supporting the grand opening of MCI and we look forward to a long and healthy relationship on the other side of COVID-19," said Colleen Payne-Nabors MCI COO.

MCI staff attending the ribbon cutting ceremony were Donnie Nabors, MCI CEO, Isam Berry, Drs. Chirita and Vanay Kohli, Pathologists for MCI, Kathleen Henderson, Government Contractor Administrator, Kristy James, Senior Operations Manager, and Dr. N. Denise Mitchem, MCI VP of Marketing.  

MCI's mission is to empower veterans, patients, physicians, and all of their partners with information to make clinical decisions for the best care and well-being.  MCI is committed to supporting the nation by providing accurate Coronavirus (COVID-19) testing solutions during the COVID-19 pandemic.  MCI has the capacity to process thousands of tests per day which will save lives and get our nation back to their daily normal routines.   The center offers COVID-19 Testing ? PCR COV-19, Rapid COVID 19 Antibody and COVID-19 Antigen. Laboratory Capabilities -Full Service include Bacteriology, Mycobacteriology, Mycology, Parasitology, Virology, Immunology, Chemistry, Endocrinology, Toxicology/Drug Testing, Hematology, ABO & RH Group, Molecular, Antibody Non-Transfusion, Histopathology, Cytology, and Antibody Identification.  The community can register at www.mcicovid.com to secure a test. Walk-ups are welcomed.

"It is an honor to welcome MCI to the City of Dallas, to Council District 10, and to this neighborhood. We are so thankful MCI chose to come here. The need is overwhelming, and it makes me feel good to know that we have this facility right here in our community, right down the street from one of our best communities in the city, Hamilton Park. At a time where there have not been many reasons to celebrate, this is a good thing for our community and our city. Thank you for being here and we welcome you with open arms," said McGough.

MCI Diagnostics Website:  www.mcidiagnostics.com

CONTACT: Diane Larche', [email protected], 404-273-3227

SOURCE MCI Diagnostic Center

These press releases may also interest you at 08:35 Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer Takeda (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of fruquintinib, a selective inhibitor of vascular endothelial growth factor... at 08:35 Bio-Rad Announces Life Science Group Management Changes Bio-Rad Laboratories, Inc. , a global leader in life science research and clinical diagnostics products, today announced the promotion of James J. Barry, currently Senior Vice President of Global Manufacturing, to the position of Executive Vice... at 08:33 1MD Nutrition Joins Hands With The Arthritis Foundation To Address Healthy Movement; The Relationship Kicks Off May, 2024 During Arthritis Awareness Month 1MD Nutrition, a leading developer of physician-formulated, condition-specific nutritional supplements with key ingredients in therapeutically significant dosages from substantiated, human clinical trials, is now a "Proud Partner" of the... at 08:25 Nova Leap Health Corp. Announces Execution of Definitive Agreement NOVA LEAP HEALTH CORP. ("Nova Leap" or "the Company"), a growing home health care organization, is pleased to announce that it has executed a definitive agreement (the "Agreement"), dated April 25, 2024, to acquire a home care services company ("the... at 08:20 Coya Therapeutics Presents Updated ALS Biomarker Data at the 2nd Annual Johnson Center Symposium Coya Therapeutics, Inc. ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, announces that Dr. Stanley Appel, M.D., Chairman of Coya's Scientific Advisory... at 08:19 New President Appointed for Nitto Denko Avecia Inc. Nitto Denko Avecia Inc. and Nitto Denko Avecia Pharma Services (Nitto Avecia), a global leader in contract development and manufacturing of oligonucleotides for the therapeutic market announced today that Tammy Cooper will be appointed President of... More news about Health...

News published on 27 november 2020 at 08:00 and distributed by: